Citations

Citations to this article as recorded by  

• Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer
  Hongyu Gao, Dengjie Ouyang, Xinyu Guan, Jiachi Xu, Qitong Chen, Liyun Zeng, Jian Pang, Qiongyan Zou, Ke Qian, Wenjun Yi
  BMC Cancer.2024;[Epub]     CrossRef
• Precision unveiled: Synergistic genomic landscapes in breast cancer—Integrating single‐cell analysis and decoding drug toxicity for elite prognostication and tailored therapeutics
  Chenglu Jiang, Shengke Zhang, Lai Jiang, Zipei Chen, Haiqing Chen, Jinbang Huang, Jingyi Tang, Xiufang Luo, Guanhu Yang, Jie Liu, Hao Chi
  Environmental Toxicology.2024;[Epub]     CrossRef
• Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer
  Uiju Cho, Soyoung Im, Hyung Soon Park
  Journal of Pathology and Translational Medicine.2024; 58(2): 49.     CrossRef
• Predictive and Prognostic Role of Tumor‐Infiltrating Lymphocytes in Patients with Advanced Breast Cancer Treated with Primary Systemic Therapy
  Gaurav Agarwal, K. M. M. Vishvak Chanthar, Shweta Katiyar, Niraj Kumari, Narendra Krishnani, M. Sabaretnam, Gyan Chand, Anjali Mishra, Punita Lal
  World Journal of Surgery.2023; 47(5): 1238.     CrossRef
• The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
  Ruonan Li, Lili Cao
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Using Self-Assembling ADDomer Platform to Display B and T Epitopes of Type O Foot-and-Mouth Disease Virus
  Chaowei Luo, Quanhui Yan, Juncong Huang, Jiameng Liu, Yuwan Li, Keke Wu, Bingke Li, Mingqiu Zhao, Shuangqi Fan, Hongxing Ding, Jinding Chen
  Viruses.2022; 14(8): 1810.     CrossRef
• Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
  Guilan Shi, Megan Scott, Cathryn G. Mangiamele, Richard Heller
  Pharmaceutics.2022; 14(11): 2429.     CrossRef
• Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy
  Bacinschi Xenia Elena, Laurentia Nicoleta Gales, Anca Florina Zgura, Laura Iliescu, Rodica Maricela Anghel, Bogdan Haineala, Xiaosheng Wang
  Journal of Oncology.2021; 2021: 1.     CrossRef
• Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
  Kyung Un Choi, Ahrong Kim, Jee Yeon Kim, Ki Hyung Kim, Chungsu Hwang, So Jung Lee, Won Young Park, Sejin Jung, Hye Jeong Choi, Kyungbin Kim
  Journal of Ovarian Research.2020;[Epub]     CrossRef

• Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review

  
  Weilin Xu, Xiu Chen, Fei Deng, Jian Zhang, Wei Zhang, Jinhai Tang
  OncoTargets and Therapy.2020; Volume 13: 5887.     CrossRef
• Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
  Sandra V. Fernandez, Alexander W. MacFarlane, Mowafaq Jillab, Maria F. Arisi, Jennifer Yearley, Lakshmanan Annamalai, Yulan Gong, Kathy Q. Cai, R. Katherine Alpaugh, Massimo Cristofanilli, Kerry S. Campbell
  Breast Cancer Research.2020;[Epub]     CrossRef
• Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
  C. Van Berckelaer, C. Rypens, P. van Dam, L. Pouillon, M. Parizel, K. A. Schats, M. Kockx, W. A. A. Tjalma, P. Vermeulen, S. van Laere, F. Bertucci, C. Colpaert, L. Dirix
  Breast Cancer Research.2019;[Epub]     CrossRef
• The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
  Anna Glajcar, Joanna Szpor, Diana Hodorowicz-Zaniewska, Katarzyna Ewa Tyrak, Krzysztof Okoń
  Virchows Archiv.2019; 475(1): 13.     CrossRef
• Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models
  Ana S. Leal, Kayla Zydeck, Sarah Carapellucci, Lyndsey A. Reich, Di Zhang, Jessica A. Moerland, Michael B. Sporn, Karen T. Liby
  npj Breast Cancer.2019;[Epub]     CrossRef
• Stromal tumor‑infiltrating lymphocytes evaluated on H&E‑stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
  Chungsu Hwang, So Lee, Jung Lee, Ki Kim, Dong Suh, Byung‑Su Kwon, Kyung Choi
  Oncology Letters.2019;[Epub]     CrossRef
• The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
  Nobumoto Tomioka, Manabu Azuma, Mayuko Ikarashi, Mitsugu Yamamoto, Masako Sato, Ken-ichi Watanabe, Katsushige Yamashiro, Masato Takahashi
  Breast Cancer.2018; 25(1): 34.     CrossRef
• Triple negative breast cancer – prognostic role of immune-related factors: a systematic review
  Elisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall, Eva Balslev
  Acta Oncologica.2018; 57(1): 74.     CrossRef
• Lack of effective translational regulation of PLD expression and exosome biogenesis in triple-negative breast cancer cells
  Julian Gomez-Cambronero
  Cancer and Metastasis Reviews.2018; 37(2-3): 491.     CrossRef
• Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Breast Cancers
  So Jeong Lee, Cheong-Soo Hwang, Young-Keum Kim, Hyun Jung Lee, Sang-Jeong Ahn, Nari Shin, Jung Hee Lee, Dong Hoon Shin, Kyung Un Choi, Do Youn Park, Chang Hun Lee, Gi Young Huh, Mi Young Sol, Hee Jin Lee, Gyungyub Gong, Jee Yeon Kim, Ahrong Kim
  Cancer Research and Treatment.2017; 49(2): 313.     CrossRef
• Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes
  Joo Young Kim, Sun-Hee Heo, Seul Ki Choi, In Hye Song, In Ah Park, Young-Ae Kim, Hye Seon Park, Suk Young Park, Won Seon Bang, Gyungyub Gong, Hee Jin Lee
  Virchows Archiv.2017; 470(4): 381.     CrossRef
• Whole Slide Imaging for Analytical Anatomic Pathology and Telepathology: Practical Applications Today, Promises, and Perils
  Alton Brad Farris, Cynthia Cohen, Thomas E. Rogers, Geoffrey H. Smith
  Archives of Pathology & Laboratory Medicine.2017; 141(4): 542.     CrossRef
• Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility
  Andrea Ravelli, Giandomenico Roviello, Daniele Cretella, Andrea Cavazzoni, Alessandra Biondi, Maria Rosa Cappelletti, Laura Zanotti, Giuseppina Ferrero, Marco Ungari, Fabrizio Zanconati, Alberto Bottini, Roberta Alfieri, Pier Giorgio Petronini, Daniele Ge
  Tumor Biology.2017; 39(4): 101042831769502.     CrossRef
• Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
  In Hye Song, Sun-Hee Heo, Won Seon Bang, Hye Seon Park, In Ah Park, Young-Ae Kim, Suk Young Park, Jin Roh, Gyungyub Gong, Hee Jin Lee
  Cancer Research and Treatment.2017; 49(2): 399.     CrossRef
• Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?
  Weiwei Zhao, Peng Wang, Huixun Jia, Menglei Chen, Xiaoli Gu, Minghui Liu, Zhe Zhang, Wenwu Cheng, Zhenyu Wu
  BMC Cancer.2017;[Epub]     CrossRef
• Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
  Ahrong Kim, So Jeong Lee, Young Keum Kim, Won Young Park, Do Youn Park, Jee Yeon Kim, Chang Hun Lee, Gyungyub Gong, Gi Yeong Huh, Kyung Un Choi
  Scientific Reports.2017;[Epub]     CrossRef
• Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer
  Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Seoung Wan Chae, Kyungeun Kim, Jin Hee Sohn, Jung-Soo Pyo, Hyun Joo Lee, Dong Hyun Kim, Sukjoong Oh, Seon Hyeong Choi, Yong Lai Park, Chan Heun Park, Eun-Kyung Kim, Mi Jung Kwon, Jinwon Seo, Kyoung Min Moon
  Virchows Archiv.2016; 468(4): 409.     CrossRef
• Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor‐infiltrating lymphocytes (TILs) in breast cancer
  Hee Jin Lee, Ahrong Kim, In Hye Song, In Ah Park, Jong Han Yu, Jin Hee Ahn, Gyungyub Gong
  Pathology International.2016; 66(4): 202.     CrossRef
• Clinical pharmacologic aspects of immune checkpoint inhibitors in cancer therapy
  Kyu-pyo Kim, Hun Jung
  Translational and Clinical Pharmacology.2016; 24(1): 7.     CrossRef
• The next level of 3D tumour models: immunocompetence
  Agata Nyga, Joana Neves, Katerina Stamati, Marilena Loizidou, Mark Emberton, Umber Cheema
  Drug Discovery Today.2016; 21(9): 1421.     CrossRef
• An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes
  Ahrong Kim, Sun-Hee Heo, Young-Ae Kim, Gyungyub Gong, Hee Jin Lee
  American Journal of Clinical Pathology.2016; 146(1): 137.     CrossRef
• High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer
  Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Jung-Soo Pyo, Seoung Wan Chae, Jin Hee Sohn, Kyungeun Kim, Hyun Joo Lee, Dong Hyun Kim, Sukjoong Oh, Seon Hyeong Choi, Yong Lai Park, Chan Heun Park, Mi Jung Kwon, Kyoung Min Moon
  Postgraduate Medical Journal.2016; 92(1094): 707.     CrossRef
• Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
  Changro Lee, Seho Park, Joo Heung Kim, Sung Mook Lim, Hyung Seok Park, Seung Il Kim, Byeong-Woo Park
  Journal of Breast Cancer.2016; 19(4): 385.     CrossRef

Mucinous cystadenocarcinoma (MCA) in the breast is a rare neoplasm. There have been 13 cases of primary breast MCA reported. The MCA presents as a large, partially cystic mass in postmenopausal woman with a good prognosis. The microscopic findings resemble those of ovarian, pancreatic, or appendiceal MCA. The aspiration findings showed mucin-containing cell clusters in the background of mucin and necrotic material. The cell clusters had intracytoplasmic mucin displacing atypical nuclei to the periphery. Histologically, the tumor revealed an abundant mucin pool with small floating clusters of mucin-containing tumor cells. There were also small cysts lined by a single layer of tall columnar mucinous cells, resembling those of the uterine endocervix. The cancer cells were positive for mucin (MUC) 5 and negative for MUC2 and MUC6. This mucin profile is different from ordinary mucinous carcinoma and may be a unique characteristic of breast MCA.

Citations

Citations to this article as recorded by  

• Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations
  Wei‐Yu Chen, Yu‐Hsuan Hu, Yu‐Hsin Tsai, Jen‐Fan Hang, Puay Hoon Tan, Chih‐Jung Chen
  Histopathology.2024; 84(3): 550.     CrossRef
• Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
  Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar
  Clinical Case Reports.2024;[Epub]     CrossRef
• Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review
  Ting Lei, Yong Qiang Shi, Tong Bing Chen
  Diagnostic Pathology.2023;[Epub]     CrossRef
• Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association
  Federica Vegni, Nicoletta D’Alessandris, Angela Santoro, Giuseppe Angelico, Giulia Scaglione, Angela Carlino, Damiano Arciuolo, Michele Valente, Stefania Sfregola, Maria Natale, Alejandro Martin Sanchez, Valeria Masciullo, Gian Franco Zannoni, Antonino Mu
  Journal of Personalized Medicine.2023; 13(6): 948.     CrossRef
• Special Histologic Type and Rare Breast Tumors – Diagnostic Review and Clinico-Pathological Implications
  Benjamin Yongcheng Tan, Elaine Hsuen Lim, Puay Hoon Tan
  Surgical Pathology Clinics.2022; 15(1): 29.     CrossRef
• Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials—a case report
  Kanwalpreet Kaur, Ashini Shah, Jahnvi Gandhi, Priti Trivedi
  Journal of the Egyptian National Cancer Institute.2022;[Epub]     CrossRef
• Mucinous carcinoma of the breast: distinctive histopathologic and genetic characteristics
  Minjung Jung
  Kosin Medical Journal.2022; 37(3): 176.     CrossRef
• Primary Mucinous Cystadenocarcinoma of the Breast: A Rare Case Report With Review of Literature
  Ekta Jain, Abhishek Kumar, Raajul Jain, Shivani Sharma
  International Journal of Surgical Pathology.2021; 29(7): 740.     CrossRef
• Mucinous Cystadenocarcinoma of the Breast: Report of 2 Cases Including One With Long-Term Local Recurrence
  Anupma Nayak, Ira J. Bleiweiss, Kimberly Dumoff, Tawfiqul A. Bhuiya
  International Journal of Surgical Pathology.2018; 26(8): 749.     CrossRef
• Mucinous breast carcinoma with tall columnar cells
  N Tsoukalas, M Kiakou, M Tolia, ID Kostakis, M Galanopoulos, G Nakos, D Tryfonopoulos, G Kyrgias, G Koumakis
  The Annals of The Royal College of Surgeons of England.2018; 100(5): e132.     CrossRef
• Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
  Minjung Seong, Eun Young Ko, Boo-Kyung Han, Soo Youn Cho, Eun Yoon Cho, Se Kyung Lee, Jeong Eon Lee
  Journal of Breast Cancer.2016; 19(3): 330.     CrossRef
• Primary Mucinous Cystadenocarcinoma of the Breast with Endocervical-Like Mucinous Epithelium
  Dong-Liang Lin, Ji-Lin Hu, Shi-Hong Shao, Dong-Mei Sun, Ji-Gang Wang
  Breast Care.2013; 8(6): 445.     CrossRef